I think you do not know Brilacidin human trial history super well.
The remaining drugs have never proven their potential in human trials
Brilacidin: Successful and safe trials for 3 different human malady with 3 different administer methods. Trial 4 for COVID was not successful but gave information for the next anti-virus trial. I look forward to the Brilacidin anti-fungus trial. Your language is poor.
JT, you totally miss the point. If BeaMed is a roaring success, even if IPIX drugs are a bust, our stock could skyrocket based on the value of our holding in BeaMed alone. With that value realized the cash for drug validation may prove to be MIRACULOUS, in more ways than one. gh
No, he is stating that they now have the ability to invest in their own company, and the laser by purchasing stock, something they did not have the ability to do previously.